"Global Osteoarthritis Pain Market 2016-2020" now available at Fast Market Research

Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age). The exact etiology of osteoarthritis is not well understood, but is believed to be an outcome of mechanical and molecular events in the affected joint. Increasing age, obesity, overuse of the joint, weak thigh muscles, and genetics are some of the common risk factors. Treatment is given depending upon the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication and exercise.
Technavio's analysts forecast the global osteoarthritis pain drugs market to grow at a CAGR of 8.38% during the period 2016-2020.

Full Report Details at
- http://www.fastmr.com/prod/1175806_global_osteoarthritis_pain.aspx?afid=301

Covered in this report
The report covers the present scenario and the growth prospects of the global osteoarthritis pain drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat osteoarthritis pain. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.

The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global Osteoarthritis Pain Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Abbott Laboratories
* Johnson & Johnson
* Novartis International
* Pfizer

Other prominent vendors

* AbbVie
* Abiogen Pharma
* Afferent Pharmaceuticals
* Astellas Pharma
* BioDelivery Sciences International
* Crystal Genomics
* Cytori Therapeutics
* Daiichi Sankyo
* Eli Lilly
* Endo Pharmaceuticals Holdings
* Horizon Pharma
* iCeutica
* Iroko Pharmaceuticals
* Merck
* Nuvo Research
* Regeneron Pharmaceuticals
* Sanofi
* SantoSolve
* Techfields Pharma
* Winston Pharmaceuticals
* Yooyoung Pharmaceutical
* Zynerba Pharmaceuticals

Market driver

* Significant unmet medical needs
* For a full, detailed list, view our report

Market challenge

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Osteoarthritis Pain Global Clinical Trials Review, H1, 2016
- Osteoarthritis Pain Global Clinical Trials Review, H2, 2015
- Cancer Pain Global Clinical Trials Review, H1, 2015
- Joint Pain Global Clinical Trials Review, H1, 2015
- Osteoarthritis Global Clinical Trials Review, H1, 2016